Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2012 | Volume: 8 | Issue: 5 | Page No.: 396-402
DOI: 10.3923/ijp.2012.396.402
The Effects of Ziprasidone on Motor Functions in Experimental Parkinson Model in Mice
Fatma Sultan Kilic, Bilgin Kaygisiz, Canan Baydemir and Kevser Erol

Abstract:
The management of Parkinson’s Disease Psychosis (PDP) is a challenge requiring to diminish antiparkinson treatment or to use classical antipsychotics which worsen motor symptoms. Second generation antipsychotics are current interest to treat PDP. This study aims to examine the effects of ziprasidone, an atypical antipsychotic agent, on locomotor activity and motor functions in mice with experimental Parkinson’s disease 2.5, 5 and 10 mg kg-1 doses of ziprasidone were used. Oxotremorine was injected i.p. for inducing experimental Parkinson’s disease. Mice were observed to score Parkinson’s disease tremors; then assessed with activity meter, rotarod and grip test. The results were statistically analysed with Mann-Whitney U test There was no significant difference between groups according to Parkinson’s disease tremor scores and grip test scores. The time of standing on rotarod device was significantly higher in control group than ziprasidone 5 and 10 mg kg-1 groups. Stereotypical movements, total activity and distance were higher in ziprasidone 2.5 and 10 mg kg-1 groups than control while resting values were less than of control group. We found that ziprasidone did not deteriorate motor functions at lower dose in mice with experimentally induced Parkinson’s disease and showed a biphasic effect on stereotypical movements, total activity, distance and resting values. We concluded that ziprasidone 2.5 mg kg-1 introduces a relatively suitable dosing than ziprasidone 5 and 10 mg kg-1 doses because it didn’t worsen motor functions when considering the worsening effects of ziprasidone 5 and 10 mg kg-1 doses on rotarod test. We suggest that ziprasidone may be a safe agent at low dose in PDP.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    The Factors Affecting the Extraction Condition for Neuroprotective Activity of Centella asiatica Evaluated by Metal Chelating Activity Assay
  •    Pharmacotherapeutic Approaches of Parkinson’s Disease
  •    The Impact of Blood Glucose and Cholesterol Levels on the Manifestation of Psychiatric Disorders
  •    CNS Activity of Methanol and Acetone Extracts of Acorus calamus Leaves in Mice
How to cite this article:

Fatma Sultan Kilic, Bilgin Kaygisiz, Canan Baydemir and Kevser Erol, 2012. The Effects of Ziprasidone on Motor Functions in Experimental Parkinson Model in Mice. International Journal of Pharmacology, 8: 396-402.

DOI: 10.3923/ijp.2012.396.402

URL: https://scialert.net/abstract/?doi=ijp.2012.396.402

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom